Target intelligence / Profile preview

long intergenic non-protein coding RNA 1568 (LINC01568)

Target
LINC01568
Molecular classification
Long non-coding RNA (lncRNA), Non-protein coding RNA
01

Overview

long intergenic non-protein coding RNA 1568 (abbreviated as LINC01568 and also known as LOHAN2) is a human long non-coding RNA (lncRNA) gene located on chromosome 16[1][2][9]. It is named for its upregulation and potential oncogenic function in head and neck cancers[1][7]. lncRNAs like LINC01568 typically do not encode proteins but participate in regulating gene expression at transcriptional and post-transcriptional levels. In cancer contexts, certain lncRNAs act as oncogenes, promoting tumor growth, proliferation, migration, and metastasis. Although many lncRNAs (including LINC01568) are emerging as therapeutic targets and potential biomarkers in oncology—especially in head and neck malignancies—the precise molecular mechanisms and validated therapeutic interventions for LOHAN2/LINC01568 remain under current investigation[5][7][9][10].

Other names
lncRNA oncogene in head and neck cancer 2LOHAN2LINC01568
02

Mechanism of action

General mechanisms targeting lncRNAs include RNA interference (e.g., siRNA, antisense oligonucleotides) and nonspecific effects of chemotherapies that modulate lncRNA expression in cancer cells

03

Biological functions

Regulation of gene expressionModulation of cell proliferationPotential involvement in cell differentiationPotential modulation of cancer cell migration and invasion (based on the general function of oncogenic lncRNAs in head and neck cancer)
04

Disease associations

CancerSpecifically, head and neck cancers—including oral, laryngeal, nasopharynx, and thyroid cancers
05

Safety considerations

Off-target effects of RNA-based therapies targeting lncRNAsThe risk of affecting normal regenerative or developmental roles of lncRNAsUnintended effects due to modulation of complex regulatory networks in gene expression
06

Interacting drugs

cisplatin

2 more in the full profile.

07

Biomarkers

lncRNAs are proposed as biomarkers for diagnosis, prognosis, and monitoring therapeutic efficacy in head and neck cancersome parallels exist for LINC01568 but no direct, validated biomarkers have been uniquely specified for it

Beyond the preview

Go deeper on long intergenic non-protein coding RNA 1568 (LINC01568).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on long intergenic non-protein coding RNA 1568 (LINC01568).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call